SPR® Therapeutics aspires to bring to market a novel therapy for severe pain with its patented peripheral nerve stimulation products. We seek to provide clinicians with a simple and effective pain therapy to reduce or eliminate their patients' pain and ultimately improve their patients' quality of life. Over 75 million Americans suffer from severe pain In many cases, the pain is totally debilitating, resulting in a negative impact on quality of life, sleep, and mental health. Up to 45% of the US population is expected to seek medical care for persistent pain. Over $90 billion is spent on pain, including direct medical expenses, workers' compensation, and legal expenses. Some 4 billion work days are lost each year due to severe pain that result in a financial loss of $79 billion per year to the economy.